# AdaptHealth (AHCO) — Earnings

AHCO · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/ahco/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q2 2026 |
| Period end | Jun 30, 2026 |
| EPS actual | $0.16 |
| EPS estimate | $0.17 |
| EPS surprise | −5.15% |
| Revenue surprise | −12.57% |
| Revenue | $740.3M |
| Revenue estimate | $846.8M |
| Reported | Aug 4, 2026 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1725255/000162828026052646/ahco-20260630.htm) |
| Earnings call | [Transcript](http://o.thsi.cn/dc-d-stock-america.teleconference/7115bdb8-a0ec-1732-06d4-b60c5596c03b.html) |

AdaptHealth reported Q2 2026 results on August 4, 2026. Earnings per share were $0.16, short of the $0.17 estimate by 5.15%. Revenue of $740.3 million came in 12.57% below the $846.8 million consensus. Compared with Q2 2025, EPS fell about 27% from $0.22 and revenue fell about 7.5% from $800.4 million.

The longer record shows earnings peaking in 2023. Annual EPS rose from $0.65 in 2022 to $1.26 in 2023, then eased to $0.96 in 2024 and $0.72 in 2025. Annual revenue held near $3.2 billion from 2023 to 2025. The first half of 2026 adds up to $0.10 per share, against $0.25 a year earlier, after a loss of $0.06 per share in Q1 2026, the only loss in the table. Q4 2023 holds the highs here at $0.56 per share and $858.2 million in revenue. Q2 2026 revenue was the lowest since Q2 2022. Over the last 20 quarters, AdaptHealth's EPS came in above the estimate 8 times, while revenue beat the consensus 15 times.

AdaptHealth reported Q3 between November 4 and November 8 in each of the past five years. That points to early November 2026 for the next report.

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q2 2026 | Aug 4, 2026 | $0.17 | $0.16 | -5.15% | $846.8M | $740.3M |
| Q1 2026 | May 5, 2026 | $0.01 | −$0.06 | -545.60% | $796.6M | $819.8M |
| Q4 2025 | Feb 24, 2026 | $0.35 | $0.23 | -35.21% | $830.0M | $846.3M |
| Q3 2025 | Nov 4, 2025 | $0.24 | $0.24 | -1.66% | $799.3M | $820.3M |
| Q2 2025 | Aug 5, 2025 | $0.16 | $0.22 | 38.26% | $803.8M | $800.4M |
| Q1 2025 | May 6, 2025 | $0.05 | $0.03 | -42.16% | $764.8M | $777.9M |
| Q4 2024 | Feb 25, 2025 | $0.28 | $0.43 | 51.53% | $829.2M | $856.6M |
| Q3 2024 | Nov 5, 2024 | $0.19 | $0.22 | 17.20% | $809.3M | $805.9M |
| Q2 2024 | Aug 6, 2024 | $0.19 | $0.22 | 16.15% | $802.6M | $806.0M |
| Q1 2024 | May 7, 2024 | $0.05 | $0.09 | 96.22% | $769.9M | $792.5M |
| Q4 2023 | Feb 27, 2024 | $0.19 | $0.56 | 188.68% | $825.5M | $858.2M |
| Q3 2023 | Nov 7, 2023 | $0.20 | $0.42 | 110.17% | $796.6M | $804.0M |
| Q2 2023 | Aug 8, 2023 | $0.13 | $0.23 | 73.02% | $765.2M | $793.3M |
| Q1 2023 | May 9, 2023 | $0.10 | $0.05 | -46.96% | $756.5M | $744.6M |
| Q4 2022 | Feb 27, 2023 | $0.31 | $0.05 | -82.51% | $788.1M | $780.3M |
| Q3 2022 | Nov 8, 2022 | $0.31 | $0.22 | -28.25% | $737.9M | $756.5M |
| Q2 2022 | Aug 9, 2022 | $0.29 | $0.18 | -38.02% | $724.2M | $727.6M |
| Q1 2022 | May 10, 2022 | $0.21 | $0.20 | -1.02% | $651.4M | $706.2M |
| Q4 2021 | Feb 24, 2022 | $0.38 | $0.29 | -23.74% | $689.9M | $702.1M |
| Q3 2021 | Nov 4, 2021 | $0.35 | $0.34 | -1.22% | $638.7M | $653.3M |

## Frequently Asked Questions

### When did AdaptHealth (AHCO) last report earnings?

AdaptHealth last reported on Aug 4, 2026, covering fiscal Q2 2026.

### Did AHCO beat earnings estimates?

No. AdaptHealth reported EPS of $0.16 for Q2 2026 against a $0.17 estimate — a 5.15% miss.

### How much revenue did AHCO report last quarter?

AdaptHealth reported $740.3M in revenue for Q2 2026, against a consensus estimate of $846.8M.

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).